BackAvidity Biosciences Overview

Avidity Biosciences Goodwill

Track Avidity Biosciences's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer average

Loading

Avidity Biosciences Goodwill History

Loading

Avidity Biosciences vs. peers: Goodwill Comparison

Loading

Avidity Biosciences Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Avidity Biosciences (RNA) FAQ

Avidity Biosciences (RNA) currently reports a goodwill of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Avidity Biosciences's goodwill history and peer comparisons.

Avidity Biosciences's goodwill changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avidity Biosciences reported $0 in goodwill as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Avidity Biosciences, and consider following RNA for alerts when major investors trade the stock.

Avidity Biosciences is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RNA with unrelated industries.